id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0567-0167,FDA,FDA-2008-N-0567,"Notice of Decision Not To Designate Coccidioidomycosis as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act",Notice,General Notice,2020-07-15T04:00:00Z,2020,7,2020-07-15T04:00:00Z,,2020-07-15T13:09:33Z,2020-15255,0,0,0900006484763953
FDA-2008-N-0567-0169,FDA,FDA-2008-N-0567,"Notice of Decision Not To Designate Clonorchiasis as an Addition to the
Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act",Notice,Designations,2020-07-15T04:00:00Z,2020,7,2020-07-15T04:00:00Z,,2020-07-15T13:52:03Z,2020-15253,0,0,09000064847639d9
FDA-2008-N-0567-0168,FDA,FDA-2008-N-0567,"Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act",Notice,Notice of Final Rule,2020-07-15T04:00:00Z,2020,7,2020-07-15T04:00:00Z,,2020-07-15T13:42:40Z,2020-15252,0,0,09000064847639a5
FDA-2008-N-0567-0170,FDA,FDA-2008-N-0567,"Designating Additions to the Current List of Tropical Diseases in the Federal
Food, Drug, and Cosmetic Act",Notice,Notice of Final Rule,2020-07-15T04:00:00Z,2020,7,2020-07-15T04:00:00Z,,2020-07-15T14:07:24Z,2020-15254,0,0,0900006484763a81
FDA-2008-N-0567-0055,FDA,FDA-2008-N-0567,"Designating Additions to the Current List of Tropical Diseases in the Federal
Food, Drug, and Cosmetic Act",Notice,Notice of Final Rule,2018-08-24T04:00:00Z,2018,8,2018-08-24T04:00:00Z,,2024-11-07T01:04:55Z,2018-18314,1,0,090000648364f86f
FDA-2008-N-0567-0081,FDA,FDA-2008-N-0567,002 Reference 1 - Chikungunya - epidemiology,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:56Z,,0,0,090000648365031a
FDA-2008-N-0567-0110,FDA,FDA-2008-N-0567,015 Reference 14 - Burden of Chikungunya in India - Estimates of DALY Lost in 2006 Epidemic,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:17Z,,0,0,09000064836505b0
FDA-2008-N-0567-0111,FDA,FDA-2008-N-0567,014 Reference 13 - Morbidity and Impaired Quality of Life 30 Months After Chikungunya Infection,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:17Z,,0,0,0900006483650340
FDA-2008-N-0567-0140,FDA,FDA-2008-N-0567,053 Reference 52 - Global Report UNAIDS Report on the Global AIDS Epidemic 2013,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:39Z,,0,0,09000064836503cd
FDA-2008-N-0567-0091,FDA,FDA-2008-N-0567,028 Reference 27 - Predictors of Pneumocystis carinii pneumonia in HIV-infected persons,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:02Z,,0,0,0900006483650546
FDA-2008-N-0567-0126,FDA,FDA-2008-N-0567,041 Reference 40 - Cost of Rabies Prevention,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:29Z,,0,0,0900006483650397
FDA-2008-N-0567-0125,FDA,FDA-2008-N-0567,"042 Reference 41 - Cryptococcosis- Epidemiology, Fungal Resistance, and New Alternatives for Treatment",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:29Z,,0,0,09000064836503be
FDA-2008-N-0567-0119,FDA,FDA-2008-N-0567,"048 Reference 47 - The Changing Epidemiology of Cryptococcosis - An Update from Population-Based Active Surveillance in 2 Large Metropolitan Areas, 1992-2000",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:25Z,,0,0,09000064836503c4
FDA-2008-N-0567-0144,FDA,FDA-2008-N-0567,049 Reference 48 - Epidemiology of Cryptococcal Meningitis in the US,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:42Z,,0,0,09000064836503c5
FDA-2008-N-0567-0057,FDA,FDA-2008-N-0567,020 Reference 19 - Burden of serious fungal infections in Tanzania,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:38Z,,0,0,0900006483650535
FDA-2008-N-0567-0137,FDA,FDA-2008-N-0567,030 Reference 29 - Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:36Z,,0,0,09000064836505ff
FDA-2008-N-0567-0068,FDA,FDA-2008-N-0567,009 Reference 8 - Polymerase chain reactions for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:45Z,,0,0,09000064836500ff
FDA-2008-N-0567-0107,FDA,FDA-2008-N-0567,018 Reference 17 - Neglected Tropical Diseases,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:15Z,,0,0,09000064836505b3
FDA-2008-N-0567-0074,FDA,FDA-2008-N-0567,003 Reference 2 - HIV Surveillance Report 2015,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:49Z,,0,0,09000064836500f9
FDA-2008-N-0567-0071,FDA,FDA-2008-N-0567,006 Reference 5 - Key Statistics for Acute Lymphocytic Leukemia,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:47Z,,0,0,09000064836500fc
FDA-2008-N-0567-0066,FDA,FDA-2008-N-0567,011 Reference 10 - AIDS-defining opportunistic illnesses in US patients,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:43Z,,0,0,09000064836502bd
FDA-2008-N-0567-0064,FDA,FDA-2008-N-0567,013 Reference 12 - Pneumocystis species,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:42Z,,0,0,09000064836502bf
FDA-2008-N-0567-0063,FDA,FDA-2008-N-0567,014 Reference 13 - Pneumocystic pneumonia CDC,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:42Z,,0,0,09000064836502c0
FDA-2008-N-0567-0108,FDA,FDA-2008-N-0567,017 Reference 16 - Severe Manifestations of Chikungunya Virus in Critically Ill Patients During the 2013-2014 Caribbean Outbreak,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:15Z,,0,0,09000064836505b2
FDA-2008-N-0567-0106,FDA,FDA-2008-N-0567,"019 Reference 18 - Lymphocytic Choriomenengitis, Lassa Fever, and South American Hemorrhagic Fevers",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:14Z,,0,0,09000064836505b4
FDA-2008-N-0567-0098,FDA,FDA-2008-N-0567,027 Reference 26 - Essential Medicines and Health Products - WHO Publishes List of Top Emerging Diseases Likely To Cause Major Epidemics,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:09Z,,0,0,09000064836505fc
FDA-2008-N-0567-0116,FDA,FDA-2008-N-0567,009 Reference 8 - Chikungunya 2015 Final Data for the United States,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:20Z,,0,0,0900006483650339
FDA-2008-N-0567-0094,FDA,FDA-2008-N-0567,025 Reference 24 - Burden of serious fungal infections in Nepal,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:04Z,,0,0,090000648365053a
FDA-2008-N-0567-0090,FDA,FDA-2008-N-0567,029 Reference 28 - Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:01Z,,0,0,0900006483650547
FDA-2008-N-0567-0077,FDA,FDA-2008-N-0567,006 Reference 5 - Towards Antivirals Against Chikungunya Virus,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:53Z,,0,0,090000648365031e
FDA-2008-N-0567-0115,FDA,FDA-2008-N-0567,010 Reference 9 - Chikungunya,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:19Z,,0,0,090000648365033a
FDA-2008-N-0567-0123,FDA,FDA-2008-N-0567,044 Reference 43 - New Approaches to the Diagnosis and Treatment of Cryptococcal Meningitis,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:27Z,,0,0,09000064836503c0
FDA-2008-N-0567-0122,FDA,FDA-2008-N-0567,045 Reference 44 - Clinical Practice Guidelines for the Management of Cryptococcal Disease,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:27Z,,0,0,09000064836503c1
FDA-2008-N-0567-0120,FDA,FDA-2008-N-0567,047 Reference 46 - Estimation of the Current Global Burden of Cryptococcal Meningitis Among Persons Living with HIV AIDS,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:26Z,,0,0,09000064836503c3
FDA-2008-N-0567-0097,FDA,FDA-2008-N-0567,022 Reference 21 - Cryptococcal disease and the burden of other fungal diseases in Uganda,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:06Z,,0,0,0900006483650537
FDA-2008-N-0567-0062,FDA,FDA-2008-N-0567,015 Reference 14 - USPHS IDSA Guidelines for the Prevention of Opportunistic infections in Persons Infected with HIV,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:41Z,,0,0,09000064836502c1
FDA-2008-N-0567-0078,FDA,FDA-2008-N-0567,005 Reference 4 - Persistent Arthralgia Associated With Chikungunya Virus,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:53Z,,0,0,090000648365031d
FDA-2008-N-0567-0136,FDA,FDA-2008-N-0567,031 Reference 30 - WHO Guide for Rabies Pre and Post Exposure Prophylaxis in Humans (updated 2014),Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:35Z,,0,0,0900006483650600
FDA-2008-N-0567-0134,FDA,FDA-2008-N-0567,"033 Reference 32 - Distribution of Risk Levels for Humans Contacting Rabies,",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:34Z,,0,0,0900006483650602
FDA-2008-N-0567-0124,FDA,FDA-2008-N-0567,043 Reference 42 - C. neoformans Infection Statistics,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:28Z,,0,0,09000064836503bf
FDA-2008-N-0567-0087,FDA,FDA-2008-N-0567,032 Reference 31 - Risk Factors for Mortality from Acute Lower Respiratory Infections in Children under Five Years of Age in Low and Middle-Income Countries,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:59Z,,0,0,090000648365054a
FDA-2008-N-0567-0072,FDA,FDA-2008-N-0567,005 Reference 4 - Transplant Activity Report Total Transplants By Year,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:48Z,,0,0,09000064836500fb
FDA-2008-N-0567-0070,FDA,FDA-2008-N-0567,007 Reference 6 - Pneumocystis pneumonia associated with human immunodeficiency virus,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:46Z,,0,0,09000064836500fd
FDA-2008-N-0567-0065,FDA,FDA-2008-N-0567,"012 Reference 11 - Increasing pneumocystis pneumonia England, UK, 2000-2010",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:43Z,,0,0,09000064836502be
FDA-2008-N-0567-0118,FDA,FDA-2008-N-0567,007 Reference 6 - The Global Virus Network Challenging Chikungunya,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:21Z,,0,0,0900006483650323
FDA-2008-N-0567-0117,FDA,FDA-2008-N-0567,008 Reference 7 - Why Arboviruses Can Be Neglected Tropical Diseases,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:20Z,,0,0,0900006483650337
FDA-2008-N-0567-0058,FDA,FDA-2008-N-0567,019 Reference 18 - Burden of serious fungal infections in Belgium,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:39Z,,0,0,0900006483650534
FDA-2008-N-0567-0096,FDA,FDA-2008-N-0567,023 Reference 22 - Estimating the burden of fungal disease in Vietnam,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:05Z,,0,0,0900006483650538
FDA-2008-N-0567-0093,FDA,FDA-2008-N-0567,026 Reference 25 - Burden of serious fungal infections in Ukraine,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:03Z,,0,0,090000648365053b
FDA-2008-N-0567-0086,FDA,FDA-2008-N-0567,033 Reference 32 - Current epidemiology of Pneumocystis pneumonia,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:59Z,,0,0,090000648365054b
FDA-2008-N-0567-0073,FDA,FDA-2008-N-0567,004 Reference 3 - 2015 UNOS Annual Report,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:48Z,,0,0,09000064836500fa
FDA-2008-N-0567-0061,FDA,FDA-2008-N-0567,016 Reference 15 - The spectrum of clinical and pathological manifestations of AIDS in a consecutive serious of autopsied patients in Mexico,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:40Z,,0,0,09000064836502c2
FDA-2008-N-0567-0104,FDA,FDA-2008-N-0567,021 Reference 20 - Acute Sensorineural Deafness in Lassa Fever,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:13Z,,0,0,09000064836505b6
FDA-2008-N-0567-0103,FDA,FDA-2008-N-0567,022 Reference 21 - Lassa Fever Confirmed in Death of U.S. Traveler Returning from Liberia,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:12Z,,0,0,09000064836505b8
FDA-2008-N-0567-0135,FDA,FDA-2008-N-0567,"032  Reference 31 - WHO Expert Consultation on Rabies, 2nd Report, WHO Technical Report Series 982 Geneva",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:35Z,,0,0,0900006483650601
FDA-2008-N-0567-0131,FDA,FDA-2008-N-0567,"036 Reference 35 - Annual Estimates of the Resident Population April 1, 2010 to July 1, 2015",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:32Z,,0,0,0900006483650390
FDA-2008-N-0567-0129,FDA,FDA-2008-N-0567,038 Reference 37 - Facts about rabies,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:31Z,,0,0,0900006483650394
FDA-2008-N-0567-0143,FDA,FDA-2008-N-0567,"050 Reference 49 - Emergence of Cryptococcus gattii--Pacific Northwest, 2004-2010",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:41Z,,0,0,09000064836503c6
FDA-2008-N-0567-0089,FDA,FDA-2008-N-0567,030 Reference 29 - Pneumocystis carinii pneumonia in patients in the developing world who have AIDS,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:01Z,,0,0,0900006483650548
FDA-2008-N-0567-0054,FDA,FDA-2008-N-0567,Notice of Decision Not To Designate Pneumocystis Pneumonia as a Tropical Disease,Notice,General Notice,2018-08-24T04:00:00Z,2018,8,2018-08-24T04:00:00Z,,2018-08-24T12:55:10Z,2018-18313,0,0,090000648364f81d
FDA-2008-N-0567-0132,FDA,FDA-2008-N-0567,"035 Reference 34 - Epidemiology of Rabies Post-Exposure Prophylaxis--United States of America, 2006-2008",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:33Z,,0,0,090000648365038f
FDA-2008-N-0567-0059,FDA,FDA-2008-N-0567,018 Reference 17 - Respiratory complications in Brazilian patients infected with HIV,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:39Z,,0,0,0900006483650533
FDA-2008-N-0567-0076,FDA,FDA-2008-N-0567,001 Reference List,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:50Z,,0,0,09000064836500f7
FDA-2008-N-0567-0079,FDA,FDA-2008-N-0567,004 Reference 3 - French Guidelines for the Management of Chikungunya,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:54Z,,0,0,090000648365031c
FDA-2008-N-0567-0105,FDA,FDA-2008-N-0567,"020 Reference 19 - Imported Lassa Fever --- New Jersey, 2004",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:13Z,,0,0,09000064836505b5
FDA-2008-N-0567-0060,FDA,FDA-2008-N-0567,017 Reference 16 - Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok Thailand,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:40Z,,0,0,09000064836502c5
FDA-2008-N-0567-0085,FDA,FDA-2008-N-0567,034 Reference 33 - Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:58Z,,0,0,090000648365054c
FDA-2008-N-0567-0083,FDA,FDA-2008-N-0567,036 Reference 35 - Neglected Tropical Diseases,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:57Z,,0,0,090000648365054e
FDA-2008-N-0567-0112,FDA,FDA-2008-N-0567,013 Reference 12 - Measuring the Burden of Arboviral Diseases The Spectrum of Morbidity and Mortality from Four Prevalent Infections,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:18Z,,0,0,090000648365033f
FDA-2008-N-0567-0133,FDA,FDA-2008-N-0567,034 Reference 33 - Rabies Surveillance in the United States During 2014,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:33Z,,0,0,090000648365038e
FDA-2008-N-0567-0130,FDA,FDA-2008-N-0567,037 Reference 36 - Rabies Fact Sheet,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:32Z,,0,0,0900006483650393
FDA-2008-N-0567-0095,FDA,FDA-2008-N-0567,024 Reference 23 - Burden of fungal infections in Senegal,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:04Z,,0,0,0900006483650539
FDA-2008-N-0567-0080,FDA,FDA-2008-N-0567,"003 Reference 2 - Seroprevalence of Chikungunya Virus Infection on Grande Comore Island, Union of the Comoros, 2005 2",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:55Z,,0,0,090000648365031b
FDA-2008-N-0567-0102,FDA,FDA-2008-N-0567,023 Reference 22 - Public Health Assessment of Potential Biological Terrorism Agents,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:12Z,,0,0,09000064836505b9
FDA-2008-N-0567-0101,FDA,FDA-2008-N-0567,024 Reference 23 - Hemorrhagic Fever Viruses as Biological Weapons,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:11Z,,0,0,09000064836505f9
FDA-2008-N-0567-0099,FDA,FDA-2008-N-0567,026 Reference 25 - 2017-2018 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:10Z,,0,0,09000064836505fb
FDA-2008-N-0567-0128,FDA,FDA-2008-N-0567,039 Reference 38 - Expert Consultation on Rabies Post-Exposure Prophylaxis,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:30Z,,0,0,0900006483650395
FDA-2008-N-0567-0127,FDA,FDA-2008-N-0567,040 Reference 39 - Immunizations and Chemoprophlaxis for the Prevention of Infectious Diseases,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:30Z,,0,0,0900006483650396
FDA-2008-N-0567-0142,FDA,FDA-2008-N-0567,051 Reference 50 - Current Trends in the Prevalence of Cryptococcus Gattii in the United States and Canada,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:40Z,,0,0,09000064836503c7
FDA-2008-N-0567-0056,FDA,FDA-2008-N-0567,021 Reference 20 - Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:37Z,,0,0,0900006483650536
FDA-2008-N-0567-0113,FDA,FDA-2008-N-0567,012 Reference 11 - Chikungunya Infection in DOD Healthcare Beneficiaries Following the 2013 Introduction of the Virus,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:18Z,,0,0,090000648365033e
FDA-2008-N-0567-0141,FDA,FDA-2008-N-0567,"052 Reference 51 - Diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children",Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:40Z,,0,0,09000064836503cc
FDA-2008-N-0567-0067,FDA,FDA-2008-N-0567,010 Reference 9 - An estimateof the burden of serious fungal diseases in Greece,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:44Z,,0,0,0900006483650500
FDA-2008-N-0567-0088,FDA,FDA-2008-N-0567,031 Reference 30 - Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:00Z,,0,0,0900006483650549
FDA-2008-N-0567-0084,FDA,FDA-2008-N-0567,035 Reference 34 - Global Report UNAIDS report on the global AIDS epidemic 2013,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:57Z,,0,0,090000648365054d
FDA-2008-N-0567-0109,FDA,FDA-2008-N-0567,016 Reference 15 - Measuring the Burden of Arboviral Diseases,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:16Z,,0,0,09000064836505b1
FDA-2008-N-0567-0138,FDA,FDA-2008-N-0567,029 Reference 28 - Rhabdoviruses,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:36Z,,0,0,09000064836505fe
FDA-2008-N-0567-0082,FDA,FDA-2008-N-0567,001 Reference List,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:56Z,,0,0,090000648365054f
FDA-2008-N-0567-0100,FDA,FDA-2008-N-0567,025 Reference 24 - Zoonoses Likely to be Used in Bioterrorism,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:10Z,,0,0,09000064836505fa
FDA-2008-N-0567-0114,FDA,FDA-2008-N-0567,011 Reference 10 - Chikungunya Virus Geographic Distribution,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:19Z,,0,0,090000648365033c
FDA-2008-N-0567-0121,FDA,FDA-2008-N-0567,046 Reference 45 - A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:26Z,,0,0,09000064836503c2
FDA-2008-N-0567-0092,FDA,FDA-2008-N-0567,027 Reference 26 - Pneumocystis pneumonia in South African children with and without HIV infection in the era of HAART,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:02Z,,0,0,090000648365053c
FDA-2008-N-0567-0075,FDA,FDA-2008-N-0567,002 Reference 1 - Pneumocystis pneumonia,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:49Z,,0,0,09000064836500f8
FDA-2008-N-0567-0069,FDA,FDA-2008-N-0567,008 Reference 7 - Current epidemiology of pneumocystis pneumonia,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:01:46Z,,0,0,09000064836500fe
FDA-2008-N-0567-0139,FDA,FDA-2008-N-0567,028 Reference 27 - 2017 Annual Review of Diseases Prioritized Under the Research and Development Blueprint,Supporting & Related Material,Background Material,2018-08-24T04:00:00Z,2018,8,,,2018-08-24T18:02:37Z,,0,0,09000064836505fd
FDA-2008-N-0567-0025,FDA,FDA-2008-N-0567,"Reference 13 - Marginalize re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act",Supporting & Related Material,Background Material,2015-08-20T04:00:00Z,2015,8,,,2015-08-20T17:00:59Z,,0,0,0900006481c28cd7
FDA-2008-N-0567-0028,FDA,FDA-2008-N-0567,"Reference 16 - Parasites--American Trypanosomiasis (also known as Chagas Disease) Detailed FAQs re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act",Supporting & Related Material,Background Material,2015-08-20T04:00:00Z,2015,8,,,2015-08-20T17:01:18Z,,0,0,0900006481c28cda
FDA-2008-N-0567-0035,FDA,FDA-2008-N-0567,"Reference 23 - Neurocysticercosis A Disease of Neglect re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act",Supporting & Related Material,Background Material,2015-08-20T04:00:00Z,2015,8,,,2015-08-20T17:02:05Z,,0,0,0900006481c28ce1
FDA-2008-N-0567-0036,FDA,FDA-2008-N-0567,"Reference 24 - The Burden of Cysticercosis re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act",Supporting & Related Material,Background Material,2015-08-20T04:00:00Z,2015,8,,,2015-08-20T17:02:13Z,,0,0,0900006481c28ce2
FDA-2008-N-0567-0037,FDA,FDA-2008-N-0567,"Reference 25 - Neurocysticercosis in the United States Review of an Important Emerging Infection re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act",Supporting & Related Material,Background Material,2015-08-20T04:00:00Z,2015,8,,,2015-08-20T17:02:19Z,,0,0,0900006481c28ce3